FACULTY: David J. Rothman
Concerns over conflicts of interest in medicineboth in medical research and in clinical practicehave grown steadily over the past few years. The marketing practices of drug companies, particularly those that involve direct contact with doctors, are falling under increasing scrutiny by state and federal policymakers. A rapid-fire succession of articles questioning the authenticity of scientific studies written by researchers with drug-industry ties not to mention those financed by the drug companies themselveshave recently appeared in the mainstream press.
David J. Rothman, Ph.D., Bernard Schoenberg Professor of Social Medicine at
“The data are overwhelming. Gifts, travel grants, consulting contracts, support for continuing medical education and speaking fees affect which drugs doctors prescribe for their patients,” says Dr. Rothman. “The system has to change, and no one is in a better position to affect change than the academic medical center.”